As of January 22, 2025, Context Therapeutics (CNTX) has a market cap of $70.333 million USD. According to our data, Context Therapeutics is ranked No.7954 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $70.33 M |
-10.69%
|
Dec 31, 2024 | $78.75 M |
-7.08%
|
Dec 29, 2023 | $84.75 M |
73.31%
|
Dec 30, 2022 | $48.90 M |
-75.49%
|
Dec 31, 2021 | $0.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Market Cap | = | CNTX Stock Price | * | CNTX Shares Outstanding |
= | $0.94 | * | 75.00 M | |
= | $70.33 M |